Related Experiment Video
Updated: Jan 28, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral
Marcella Bassetto1, Jana Van Dycke2, Johan Neyts3
1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, CF10 3NB Cardiff, UK. bassettoM@cardiff.ac.uk.
Insights
Developing a broad-spectrum antiviral treatment for viral gastroenteritis is feasible by targeting the viral polymerase, a conserved protein across common diarrhea-causing viruses like norovirus and rotavirus.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- Viral gastroenteritis causes significant global morbidity and mortality, especially in young children.
- Current treatments lack specificity against common causative agents such as noroviruses, rotaviruses, sapoviruses, astroviruses, and adenoviruses.
- There is a critical unmet need for effective antiviral therapies against these prevalent pathogens.
Purpose of the Study:
- To explore the feasibility of creating a broad-spectrum antiviral treatment for viral gastroenteritis.
- To identify the viral polymerase as a promising target for a pan-inhibitor drug.
- To review existing polymerase inhibitors and their potential for broad-spectrum application.
Main Methods:
- Review of scientific literature on viral polymerases of common gastroenteritis-causing viruses.
- Analysis of functional and structural similarities among these diverse viral polymerases.
- Evaluation of reported antiviral effects of existing polymerase inhibitors.
Main Results:
- Viral polymerases exhibit conserved functional and structural characteristics across different viral families.
- Existing polymerase inhibitors demonstrate antiviral activity against certain gastroenteritis viruses.
- Common features of viral polymerases can be exploited for designing broad-spectrum inhibitors.
Conclusions:
- The viral polymerase represents a viable and conserved target for developing broad-spectrum antiviral therapies.
- Designing a pan-polymerase inhibitor is a feasible strategy to combat viral gastroenteritis.
- Further research into common polymerase features can accelerate the development of novel antiviral treatments.
Abstract:
Viral gastroenteritis is an important cause of morbidity and mortality worldwide, being particularly severe for children under the age of five. The most common viral agents of gastroenteritis are noroviruses, rotaviruses, sapoviruses, astroviruses and adenoviruses, however, no specific antiviral treatment exists today against any of these pathogens. We here discuss the feasibility of developing a broad-spectrum antiviral treatment against these diarrhea-causing viruses. This review focuses on the viral polymerase as an antiviral target, as this is the most conserved viral protein among the diverse viral families to which these viruses belong to. We describe the functional and structural similarities of the different viral polymerases, the antiviral effect of reported polymerase inhibitors and highlight common features that might be exploited in an attempt of designing such pan-polymerase inhibitor.
Related Concept Videos
Viral Recombination
Targeted Cancer Therapies
There are several types of targeted therapies against...
What are Viruses?
The Electromagnetic Spectrum
Viral Structure
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...

